Therapy-related changes in lactate dehydrogenase levels. Lactate dehydrogenase levels before (weeks −2 and −1), during (weeks 0 through 26; solid bar), and after eculizumab treatment (weeks 27 through 34) in 13 patients with CAD (median ± IQR).